EBOLA Treatments and detection Patent activity comes mainly from US public organizations Ebola is a disease of humans and other primates caused by an ebolavirus. No specific treatment for the disease is yet available. Efforts to help those who are infected are supportive and include giving either oral rehydration therapy or intravenous fluids. The disease has a high risk of death, killing between 50% and 90% of those infected with the virus.

1. FLASH Patent Landscape
EBOLA
Treatments and detection
Patenting activity
Number of patent families*
Top 10 applicants
Total number
of patent families*
890
Regional distribution
Number of patent families* by region of filing
of patent families*
received at least one
granted patent
Patent activity comes mainly from US public organizations
Ebola is a disease of humans and other primates caused by an ebolavirus. No specific treatment for the disease is yet available. Efforts to help those who are infected are supportive and include giving either oral rehydration therapy or intravenous fluids. The disease has a high risk of death, killing between 50% and 90% of those infected with the virus.
38%
0
50
100
150
200
250
0
10
20
30
40
50
60
70
80
90
CRUCELL (NL)
UNIV. OF TEXAS (US)
EMORY UNIV. (US)
US GOVERNMENT (US)
UNIV. OF CALIFORNIA (US)
BIOCRYST PHARMA. (US)
HARVARD COLLEGE (US)
US ARMY (US)
HHS (US)
NIH (US)
630+
330+
30+
150+
600+
130+
340+
450+
KNOWMADE www.knowmade.com
contact@knowmade.fr
67%
28%
5%
Treatments
Detection
Others
*A patent family is a set of patent filings made in various countries to protect a single invention.
October 2014
Number of patent families*
Legal status
Technologies